Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes
Laia Gómez-Muñoz, David Perna‐Barrull, Adrian Villalba, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 20

Showing 20 citing articles:

Human immune phenotyping reveals accelerated aging in type 1 diabetes
Melanie R. Shapiro, Xiaoru Dong, Daniel J. Perry, et al.
JCI Insight (2023) Vol. 8, Iss. 17
Open Access | Times Cited: 17
Glucocorticoids and natural killer cells: A suppressive relationship
Isabella Muscari, Alessandra Fierabracci, Sabrina Adorisio, et al.
Biochemical Pharmacology (2022) Vol. 198, pp. 114930-114930
Closed Access | Times Cited: 19
Tissue Resident and Infiltrating Immune Cells: Their Influence on the Demise of Beta Cells in Type 1 Diabetes
Sophie Walker, Pia Leete, Joanne Boldison
Biomolecules (2025) Vol. 15, Iss. 3, pp. 441-441
Open Access
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches
Vahid Mohammadi, Armin Jahani Maleki, Mahdis Nazari, et al.
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 3, pp. 585-600
Closed Access | Times Cited: 9
Immunoregulatory natural killer cells
Kevin Roe
Clinica Chimica Acta (2024) Vol. 558, pp. 117896-117896
Closed Access | Times Cited: 3
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
Laia Gómez-Muñoz, David Perna‐Barrull, Josep M. Caroz-Armayones, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Single-Cell RNA Sequencing of Peripheral Blood Mononuclear Cells From Pediatric Coeliac Disease Patients Suggests Potential Pre-Seroconversion Markers
Aarón D. Ramírez-Sánchez, Xiaojing Chu, Rutger Modderman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Establishing evidence for immune surveillance of β-cell senescence
Nayara Rampazzo Morelli, Jasmine Pipella, Peter J. Thompson
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 7, pp. 576-585
Closed Access | Times Cited: 2
Approaches to Measuring Beta Cell Reserve and Defining Partial Clinical Remission in Paediatric Type 1 Diabetes
Elaine Kennedy, Colin P. Hawkes
Children (2024) Vol. 11, Iss. 2, pp. 186-186
Open Access | Times Cited: 2
Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes
Hugo Barcenilla, Mikael Pihl, Jeanette Wahlberg, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 11
Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents
Elizabeth K. Wood, Brie M. Reid, Dagna Sheerar, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 456-456
Open Access | Times Cited: 1
Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes
Camillo Bechi Genzano, Eugenia Bezzecchi, Debora Carnovale, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion
Laia Gómez-Muñoz, David Perna‐Barrull, Marta Murillo, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 2, pp. 17-17
Open Access | Times Cited: 3
Recovery of intracellular glucose uptake in T cells during partial remission of type 1 diabetes
Rong Tang, Ting Zhong, Kang Lei, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1532-1543
Closed Access | Times Cited: 2
Comprehensive Analyses of Type 1 Diabetes Ketosis- or Ketoacidosis-Related Genes in Activated CD56+CD16+ NK Cells
Ruifeng Shi, Fang Dai, Yong He, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 4
PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target
Naoya Iwamoto, Hideya Onishi, Shogo Masuda, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 16, pp. 14619-14630
Closed Access | Times Cited: 1
Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus
Laia Gómez-Muñoz, Juan Domínguez‐Bendala, Ricardo L. Pastori, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 2, pp. 151-163
Closed Access | Times Cited: 1
COVID-19 infection and inactivated vaccination: Impacts on clinical and immunological profiles in Chinese children with type 1 diabetes
Zhenran Xu, Li Xi, Jing Wu, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 12, pp. 2276-2284
Closed Access
What Is a Honeymoon in Type 1, Can It Go into Remission?
Anuradha Viswanathan, Jamie Wood, Betül Hatipoğlu
Endocrinology and Metabolism Clinics of North America (2022) Vol. 52, Iss. 1, pp. 175-185
Closed Access | Times Cited: 2
Lower percentages of natural killer cells in children with type 1 diabetes and their siblings
Joanna Sieniawska, Aleksandra Krzewska, Anna Skowronek, et al.
Pediatric Endocrinology Diabetes and Metabolism (2023) Vol. 29, Iss. 4, pp. 214-224
Open Access
Page 1

Scroll to top